oncnursingnews21hOpinion
Opinion: Subcutaneous Nivolumab Offers an Effective Alternative to Intravenous Administration
Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...
Hosted on MSN10mon
Ivy Rx NAD+ Review - Are Anti-Aging Injections Worth It?
Ivy Rx is a telehealth platform offering various treatments, including nicotinamide adenine dinucleotide (NAD+), for age-related concerns. Its holistic treatment plans are designed for adults ...
The American Journal of Managed Care13d
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
Cure Today2d
Delving into Subcutaneous Versus Intravenous Opdivo in Solid Tumors
Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...
Cure Today7d
Understanding the Benefit of Subcutaneous Versus IV Opdivo in Patients With Solid Tumors
Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for ...
Healio20d
FDA approves Opdivo as subcutaneous injection
Please provide your email address to receive an email when new articles are posted on . Opdivo was previously only available intravenously. The approval comes after CHECKMATE-67T study results.